Abstract
EVALUATION OF DIARRHEA IN COVID-19 INFECTION AMONG HOSPITALIZED PATIENTS IN A TERTIARY HOSPITAL
M.F.N De Leon, MD; M.A.V. Chu, MD;L.B. Gatchalian, MD; M.Talingdan-Te, MD; S.D. Preza-Carmona, MD
Section of Gastroenterology, Department of Internal Medicine , East Avenue Medical Center, East Avenue, Diliman, Quezon City, Philippines
Significance: Experimental studies suggest that SARS-CoV-2 infects and replicates in the GIT. This study aims to determine the prevalence and clinicodemographic profile of patients with diarrhea in COVID patients and its association with disease outcome.
Methodology: This is a retrospective, cross-sectional study on the clinical characteristics of COVID patients admitted at a tertiary government hospital who presented with diarrhea. Mild, moderate, severe, and critical disease were included in the study.
Results: A total of 137 COVID-19 patients were included in the study and 66 (48.18%) experienced diarrhea. Only 28.79% of them have comorbidities, most of them having hypertension. Majority of patients with diarrhea were diagnosed with moderate COVID disease (33.33%). Patients with mild disease have 3 BM per day, patients with moderate disease have 4 BM per day, those with severe disease have 5 and critical patients have 4 BM per day. For the duration of diarrhea, mild disease have an average duration of 40 hours, moderate disease have an average duration of 43 hours, severe disease with an average of 64 hours and critical patients with diarrhea for an average of 51 hours. Majority have mushy consistency of stools. The presence of diarrhea has no significant association with the length of hospital stay (p-value= 0.9987) and outcome of patients (OR= 0.9987).
Conclusion: There is no significant difference among COVID patients with and without diarrhea in terms of length of hospital stay and mortality. There is a trend towards increasing number of bowel movements in more severe cases of COVID infection.
Keywords: Retrospective; COVID-19; diarrhea; Filipino patients
Important Dates to Remember
| JRRE Activities 2023-2024 |
Proposed Dates |
|---|---|
| Resumption of face-to-face Evidence-Based Medicine Workshop Venue to be announced once finalized. |
July 21, 2023 (Friday), 1-5pm |
| Monthly Critical Appraisal of Topics Conferences to be gaciliated by Research Coordinators per Institution | Monthly Critical Appraisal of Topics Conferences per Institution |
| CAT Plenary/Liver Con Dates: September 23, 2023 December 16, 2023 March 2024 (During the JAC) Resumption of face-to-face Quarterly Critical Appraisal of Topics facilitated by the JRRE |
2 Clinical scenarios and articles are to be sent to institutions each on August 2023, November 2023, and February 2024; |
| Hybrid Research Workshop 4 week asynchronous via Moodle, followed by a 1 day on-site Onsite Workshop Research Protocol Presentation for Level I GI Fellows-In-Training - Research Protocol Presentation: August 12, 2023 - Research Forums of the Tripartite Societies |
Week 1: July 15-21, 2023 Week 2: July 22-28, 2023 Week 3: July 29-August 4, 2023 Week 4: August 5-11, 2023 |
| Research Manuscript Workshop for level II GI Fellows-In-Training | January 6, 2024 |